Novavax
NVAX
#5751
Rank
โ‚น100.87 B
Marketcap
โ‚น620.77
Share price
0.73%
Change (1 day)
-11.68%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚น31.39 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚น1.02 Billion. In 2024 the company made an earning of -โ‚น14.07 Billion, an increase over its 2023 earnings that were of -โ‚น47.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น31.39 B-323.21%
2024 -โ‚น14.07 Billion-70.39%
2023 -โ‚น47.49 Billion-16.59%
2022 -โ‚น56.94 Billion-62.58%
2021 -โ‚น152.17 Billion320.54%
2020 -โ‚น36.19 Billion234.22%
2019 -โ‚น10.83 Billion-30.17%
2018 -โ‚น15.51 Billion1.69%
2017 -โ‚น15.25 Billion-36.44%
2016 -โ‚น23.99 Billion70.4%
2015 -โ‚น14.08 Billion89.27%
2014 -โ‚น7.44 Billion59.83%
2013 -โ‚น4.66 Billion81.9%
2012 -โ‚น2.56 Billion50.33%
2011 -โ‚น1.71 Billion
2009 -โ‚น3.36 Billion8.8%
2008 -โ‚น3.09 Billion18.01%
2007 -โ‚น2.62 Billion18.33%
2006 -โ‚น2.22 Billion168.31%
2005 -โ‚น0.83 Billion-62.51%
2004 -โ‚น2.2 Billion52.4%
2003 -โ‚น1.45 Billion-28.21%
2002 -โ‚น2.01 Billion
2000 -โ‚น1.15 Billion177%
1999 -โ‚น0.42 Billion-11.54%
1998 -โ‚น0.47 Billion10.64%
1997 -โ‚น0.43 Billion-9.62%
1996 -โ‚น0.47 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
โ‚น1.85 B-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น22.66 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น14.84 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น0.6 Billion-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.175 T 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น1.064 T 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.475 T 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-โ‚น0.86 Billion-102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น837.53 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-โ‚น23.02 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA